Keene & Associates, Inc. Haemonetics Corp Transaction History
Keene & Associates, Inc.
- $121 Million
- Q2 2024
A detailed history of Keene & Associates, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Keene & Associates, Inc. holds 9,876 shares of HAE stock, worth $723,318. This represents 0.67% of its overall portfolio holdings.
Number of Shares
9,876
Previous 9,999
1.23%
Holding current value
$723,318
Previous $853,000
4.22%
% of portfolio
0.67%
Previous 0.64%
Shares
11 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.2MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$506 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$436 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$377 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$281 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$281 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.76B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...